Next Article in Journal
Correction: Lin et al. Huafengdan Inhibits Glioblastoma Cell Growth and Mobility by Acting on PLAU and CAV1 Targets. Pharmaceuticals 2025, 18, 428
Previous Article in Journal
Warburg-like Metabolic Reprogramming in Endometriosis: From Molecular Mechanisms to Therapeutic Approaches
Previous Article in Special Issue
Identification of Ureidocoumarin-Based Selective Discoidin Domain Receptor 1 (DDR1) Inhibitors via Drug Repurposing Approach, Biological Evaluation, and In Silico Studies
 
 
Article

Article Versions Notes

Pharmaceuticals 2025, 18(6), 814; https://doi.org/10.3390/ph18060814
Action Date Notes Link
article pdf uploaded. 28 May 2025 16:20 CEST Version of Record https://www.mdpi.com/1424-8247/18/6/814/pdf-vor
article supplementary file uploaded. 28 May 2025 16:20 CEST - https://www.mdpi.com/1424-8247/18/6/814#supplementary
article xml file uploaded 30 May 2025 10:38 CEST Original file -
article xml uploaded. 30 May 2025 10:38 CEST Update https://www.mdpi.com/1424-8247/18/6/814/xml
article pdf uploaded. 30 May 2025 10:38 CEST Updated version of record https://www.mdpi.com/1424-8247/18/6/814/pdf
article html file updated 30 May 2025 10:41 CEST Original file https://www.mdpi.com/1424-8247/18/6/814/html
Back to TopTop